ACP

Acuta Capital Partners Portfolio holdings

AUM $141M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+783.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
-$6.69M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$4.19M
2
+$3.65M
3
+$2.22M
4
TNGX icon
Tango Therapeutics
TNGX
+$2.21M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$2.19M

Top Sells

1
+$19.7M
2
+$5.8M
3
+$4.93M
4
INSM icon
Insmed
INSM
+$4.5M
5
OCUL icon
Ocular Therapeutix
OCUL
+$4.39M

Sector Composition

1 Healthcare 98.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$9.76B
$27.4M 19.46%
84,901
+1,865
TERN
2
DELISTED
Terns Pharmaceuticals
TERN
$26.1M 18.59%
495,772
-141,323
WHWK
3
Whitehawk Therapeutics
WHWK
$233M
$11.8M 8.37%
3,410,402
TNGX icon
4
Tango Therapeutics
TNGX
$3.18B
$9.24M 6.57%
441,831
+159,099
DRUG
5
Bright Minds Biosciences
DRUG
$864M
$8.17M 5.81%
111,996
+27,519
STRO icon
6
Sutro Biopharma
STRO
$484M
$6.71M 4.77%
269,425
+201,974
ERAS icon
7
Erasca
ERAS
$3.99B
$5.74M 4.08%
+354,575
SRZN icon
8
Surrozen
SRZN
$304M
$5.04M 3.58%
172,847
-5,568
OCUL icon
9
Ocular Therapeutix
OCUL
$1.97B
$5.02M 3.57%
592,108
-460,887
CMPX icon
10
Compass Therapeutics
CMPX
$429M
$4.49M 3.19%
849,076
-244,224
NERV icon
11
Minerva Neurosciences
NERV
$229M
$4.27M 3.04%
709,500
MLTX icon
12
MoonLake Immunotherapeutics
MLTX
$1.41B
$3.57M 2.54%
191,760
+132,480
ARGX icon
13
argenx
ARGX
$52B
$3.42M 2.44%
4,690
-161
OCS icon
14
Oculis Holding
OCS
$1.37B
$2.61M 1.86%
98,339
-3,438
RVMD icon
15
Revolution Medicines
RVMD
$33.5B
$2.54M 1.8%
26,069
+17,658
AMLX icon
16
Amylyx Pharmaceuticals
AMLX
$1.6B
$2.1M 1.49%
151,067
-182,191
TSHA icon
17
Taysha Gene Therapies
TSHA
$1.69B
$1.96M 1.4%
439,464
-15,363
IDYA icon
18
IDEAYA Biosciences
IDYA
$2.59B
$1.61M 1.14%
+48,234
DSGN icon
19
Design Therapeutics
DSGN
$655M
$1.55M 1.1%
145,900
-5,006
UTHR icon
20
United Therapeutics
UTHR
$23.6B
$1.32M 0.94%
2,224
-72
TRDA icon
21
Entrada Therapeutics
TRDA
$274M
$1.13M 0.8%
+89,358
AVTX icon
22
Avalo Therapeutics
AVTX
$838M
$908K 0.65%
+60,808
LBRX
23
LB Pharmaceuticals
LBRX
$802M
$713K 0.51%
28,919
-1,081
MAZE
24
Maze Therapeutics
MAZE
$1.46B
$577K 0.41%
19,335
-665
UNCY icon
25
Unicycive Therapeutics
UNCY
$197M
$381K 0.27%
57,959
-2,026
1
2